MedPath

PQ Bypass, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

TORUS I Clinical Study

Not Applicable
Conditions
Peripheral Arterial Disease
First Posted Date
2017-04-25
Last Posted Date
2020-10-19
Lead Sponsor
PQ Bypass, Inc.
Target Recruit Count
60
Registration Number
NCT03128424

The DETOUR 2 Clinical Trial

Not Applicable
Completed
Conditions
Peripheral Arterial Disease
First Posted Date
2017-04-18
Last Posted Date
2025-04-02
Lead Sponsor
Endologix
Target Recruit Count
202
Registration Number
NCT03119233
Locations
🇺🇸

HonorHealth, Scottsdale, Arizona, United States

🇺🇸

St. Bernard's Medical Center, Jonesboro, Arkansas, United States

🇺🇸

Arkansas Heart Hospital, Little Rock, Arkansas, United States

and more 31 locations

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass

Not Applicable
Completed
Conditions
Peripheral Arterial Disease
First Posted Date
2015-06-15
Last Posted Date
2025-05-23
Lead Sponsor
Endologix
Target Recruit Count
78
Registration Number
NCT02471638
Locations
🇨🇱

Universidad Católica de Chile, Santiago, Chile

🇩🇪

University of Leipzig Medical Centre, Leipzig, Germany

🇮🇹

Ospedale San Raffaele, Milan, Italy

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.